Volume 28, Number 1—January 2022
Research
Global Genome Diversity and Recombination in Mycoplasma pneumoniae
Table
Clade | No. strains | Total SNPs | No. SNPs inside recombination | No. SNPs outside recombination | No. recombination blocks | r/m | ρ/θ |
---|---|---|---|---|---|---|---|
T1–1 | 17 | 10.29 ± 23.44 | 5.65 ± 20.62 | 4.65 ± 6.78 | 0.18 ± 0.53 | 0.03 ± 0.14 | 0.01 ± 0.02 |
T1–2 | 146 | 9.78 ± 12.41 | 1.76 ± 4.06 | 8.02 ± 10.88 | 0.24 ± 0.55 | 0.25 ± 0.91 | 0.03 ± 0.12 |
T1–3 | 33 | 3.00 ± 5.70 | 0.18 ± 1.04 | 2.82 ± 5.53 | 0.03 ± 0.17 | 0.04 ± 0.21 | 0.01 ± 0.03 |
T2–2 | 46 | 14.46 ± 13.65 | 0.33 ± 1.71 | 14.13 ± 13.28 | 0.04 ± 0.21 | 0.02 ± 0.07 | 0 ± 0.01 |
T2–1 | 42 | 12.93 ± 16.71 | 1.98 ± 5.13 | 10.95 ± 12.59 | 0.26 ± 0.63 | 0.07 ± 0.17 | 0.01 ± 0.02 |
*Values are mean ± SD. r/m assesses the relative effect of recombination and mutation on genetic diversification of the clade. ρ/θ estimates the relative frequency of occurrence of recombination and mutation in the history of the clade. SNP, single-nucleotide polymorphism.
Page created: September 02, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.